or Try an Advanced Search...

    Technical Analysis for KRBP - Kiromic BioPharma, Inc.

    Grade Last Price % Change Price Change
    B 2.60 4.00% 0.10
    KRBP closed up 4.0 percent on Friday, April 19, 2024, on 10 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Flat Down
    Historical KRBP trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 4.00%
    Bollinger Band Squeeze Range Contraction 4.00%
    Narrow Range Bar Range Contraction 4.00%
    Inside Day Range Contraction 4.00%
    Wide Bands Range Expansion 4.00%
    Gapped Up Strength 4.00%
    Older End-of-Day Signals for KRBP ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 50 DMA about 21 hours ago
    Up 3% about 21 hours ago
    Up 2% about 21 hours ago
    Rose Above Previous Day's High about 22 hours ago
    Up 1% about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    KRBP Chart by TradingView
    Basic chart:

    Profile

    Kiromic BioPharma, Inc. operates as a biotechnology company. The Company focuses on target discovery and gene editing through artificial intelligence and its proprietary neural network platform with a therapeutic focus on immuno-oncology. Kiromic BioPharma serves customers in the United States.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Artificial Intelligence Neural Network

    Is KRBP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 10 Kiromic BioPharma files to withdraw registration statement
    Apr 2 Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial
    Mar 19 Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial
    Mar 8 Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
    Mar 5 Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024
    Mar 1 Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
    Feb 28 Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th
    Feb 14 Results from First Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two Months
    Jan 29 Kiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung Cancer
    Jan 5 Kiromic BioPharma Reports Favorable Early Safety and Tolerability Data from First Patient Enrolled in the Phase 1 Deltacel-01 Clinical Trial
    See more KRBP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.97
    52 Week Low 0.16
    Average Volume 7,098
    200-Day Moving Average 1.67
    50-Day Moving Average 2.59
    20-Day Moving Average 2.77
    10-Day Moving Average 2.65
    Average True Range 0.43
    RSI (14) 49.75
    ADX 26.13
    +DI 17.90
    -DI 34.03
    Chandelier Exit (Long, 3 ATRs) 2.35
    Chandelier Exit (Short, 3 ATRs) 3.01
    Upper Bollinger Bands 3.24
    Lower Bollinger Band 2.30
    Percent B (%b) 0.32
    BandWidth 34.21
    MACD Line 0.03
    MACD Signal Line 0.07
    MACD Histogram -0.0461
    Fundamentals Value
    Market Cap 3.27 Million
    Num Shares 1.26 Million
    EPS -19.51
    Price-to-Earnings (P/E) Ratio -0.13
    Price-to-Sales 0.00
    Price-to-Book 11.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.68
    Resistance 3 (R3) 2.67 2.63 2.66
    Resistance 2 (R2) 2.63 2.61 2.64 2.66
    Resistance 1 (R1) 2.62 2.60 2.63 2.63 2.65
    Pivot Point 2.58 2.58 2.59 2.59 2.58
    Support 1 (S1) 2.57 2.56 2.58 2.58 2.55
    Support 2 (S2) 2.53 2.55 2.54 2.54
    Support 3 (S3) 2.52 2.53 2.54
    Support 4 (S4) 2.53